Global NAPI Pharmaceuticals (GNP) was established as a private investment company in 1997, designed and licensed for pharmaceutical formulations production in Egypt. Since that time, with a dramatic progress and respected presence in the pharmaceuticals market, GNP not only introduced to the Egyptian market its own branded generic formulations, but also established several license agreements with multinational pharmaceutical companies like MSD, Sanofi, Pierre Fabre, Elerte and others, in addition to, manufacturing agreements with Bayer Consumer Care, Novartis, Pfizer, Roche, Boehringer Ingelheim and Stada for local Egyptian market supply. GNP products are covering a wide range of therapeutic areas, with more than 100 brand names in tablets, capsules, solutions, syrups, ointments, creams, gels, and suppositories forms.
